SCREEN – emerging technologies in 3D ex vivo imaging

In drug discovery processes, there has been a growing shift from laboratory-based 2D in vitro approaches towards 3D ex vivo-based platforms.
3D ex vivo platforms are also being developed into better drug efficacy testing systems in preclinical profiling of novel anticancer entities. Within this context, there is a growing need for improving ways to image and analyze complex 3D structures like multicellular tumor spheroids and organoids.
Our partner SCREEN has developed both fluorescence and novel OCT-based technologies which have eliminated the need for fluorescent staining.

Applications include:

  • spheroid/organoid imaging
  • growth and morphological profiling of 3D spheroids
  • quantification of internal cavities
  • drug sensitivity testings
  • large tissue imaging
  • non-invasive monitoring of macro and sprouted neo vasculature

More about High-throughput cellular imagers

Contact

Dr. Arianna Ramberti
Dr. Arianna Ramberti

Register

Newsletter registration

Contact

Quantum Design s.r.l.

Italy and Israel branch office
Via Francesco Sapori, 27
00143 Roma
Italy

Phone:+39 06 5004204
Fax:+39 06 5010389
E-mail:italy@qd-europe.com
Dr. Arianna RambertiMarketing Manager
+39 06 5004204
Write e-mail